Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Percentage of adherent patients per NOAC

From: NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands

  Pct of patients
PDC* > =80 Nr of patients
Apixaban 92% 7094
Dabigatran 88% 11,782
Rivaroxaban 88% 13,975
Total 89% 32,851